EDGAR Filing Documents for 0001193125-06-058501

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-06-058501

Filing Date

2006-03-20

Accepted

2006-03-20 06:38:22

Documents

Period of Report

2005-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d20f.htm	20-F	2793707
2	FIRST SUPPLEMENTAL INDENTURE	dex216.htm	EX-2.16	177152
3	SECOND SUPPLEMENTAL INDENTURE	dex217.htm	EX-2.17	87785
4	SUBSIDIARIES OF THE REGISTRANT	dex8.htm	EX-8	19918
5	CONSENT OF KESSELMAN & KESSELMAN	dex101.htm	EX-10.1	2568
6	CONSENT OF ERNST & YOUNG LLP	dex102.htm	EX-10.2	1740
7	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	dex12i.htm	EX-12.I	8809
8	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	dex12ii.htm	EX-12.II	8810
9	CERTIFICATION OF THE CEO AND CFO PURSUANT TO SECTION 906	dex13.htm	EX-13	4044
	Complete submission text file	0001193125-06-058501.txt		3105972

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)